b.restrepo
TL2 · Setúbal
Contributes reviews on supplier material. Based in Setúbal.
Joined 10 May 2025 · last posted 9d
70 posts, newest first. Showing up to 150.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #50 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 13 likes Reading a rodent study is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Tracking intake honestly when appetite is absent Replied, post #77 · Nutrition & Training › Protein & intake · 28 Jun 2026 · 27 likes On post #74 — agreed on the reasoning, with one qualification. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food…
-
Prescription portability between countries Replied, post #74 · Access › International · 23 Jun 2026 · 18 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one. A weak preference rather…
-
Documenting a supplier's response to a discrepancy Replied, post #16 · Sourcing › Vendor reports · 16 Jun 2026 · 5 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. The part I am sure of is…
-
Revisiting: The best-written scientific paper you have read Replied, post #34 · Lounge › Off topic · 16 Jun 2026 · 0 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #56 · Compounds › Semaglutide · 8 Jun 2026 · 28 likes Building on post #53 rather than restating it. The most useful thing anyone has posted about semaglutide and gastric emptying in this category was a table of what had…
-
Injecting into an area that has become firm: why not to Replied, post #32 · Practice › Administration · 8 Jun 2026 · 13 likes Post #30 describes the usual case. This is about the unusual one. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the…
-
Request: a per-category review queue Replied, post #16 · Meta › Feature requests · 3 Jun 2026 · 4 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #51 · Clinical › Comorbidities · 1 Jun 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Second pass at: Cost versus information: making the trade-off explicitly Started this topic · Analytics › Home & field testing · 28 May 2026 · 27 likes Posting this under the heading it deserves: Second pass at: Cost versus information: making the trade-off explicitly Everything below is what sits behind that. Posting…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #53 · Devices › Syringes & needles · 27 May 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #42 · Practice › Storage & stability · 25 May 2026 · 3 likes Everything in post #38 holds. The case it does not cover is the one I have. Visible particulate is a strong signal in the other direction: it is a reason to stop and…
-
When your prescriber and the evidence disagree Replied, post #12 · Clinical › Prescriber conversations · 15 May 2026 · 10 likes If you have been doing something the prescriber does not know about, saying so is more useful than not. Clinicians here consistently say they would rather know.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #13 · Analytics › Impurities & related substances · 7 May 2026 · 2 likes Post #11 and I disagree about the size of the effect, not about the direction. Racemisation produces a diastereomer that is mass-identical and chromatographically…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #109 · Practice › Reconstitution · 6 May 2026 · 17 likes Counterpoint on reconstitution volumes, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #49 · Clinical › Bloodwork · 25 Apr 2026 · 31 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #99 · Analytics › Mass spectrometry · 20 Apr 2026 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #88 · Practice › Dosing & titration · 8 Apr 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Grapefruit: why this class is not the class that cares Replied, post #132 · Practice › Interactions · 7 Apr 2026 · 18 likes Post #130 is right about the mechanism and I think understates the practical bit. An honest declaration on grapefruit: I have a prior here and it is strong enough that…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #31 · Evidence › Journal club · 4 Apr 2026 · 0 likes Picking up post #29: that is the part I would want checked first. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Journal club: is percentage weight change the right endpoint? Replied, post #38 · Evidence › Journal club · 4 Apr 2026 · 16 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Coming back to: Time to steady state after a dose increase Replied, post #22 · Pharmacology › Pharmacokinetics · 28 Mar 2026 · 29 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #14 · Evidence › Preprints · 20 Mar 2026 · 12 likes Post #12 answers the question as asked. The question underneath it is different. The honest position on most preprints in this field is that they are interesting and…
-
Cold solution and stinging: the simplest fix Replied, post #9 · Practice › Administration · 20 Mar 2026 · 0 likes The version of cold solution and stinging that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #9 · Evidence › Journal club · 16 Mar 2026 · 22 likes Worth separating two things that post #7 runs together. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #91 · Practice › Storage & stability · 4 Mar 2026 · 0 likes Post #87 describes the usual case. This is about the unusual one. Storing lyophilised material long term: I have looked for the primary source twice and failed twice.…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #56 · Analytics › Mass spectrometry · 3 Mar 2026 · 6 likes On Adducts: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #89 · Evidence › Study critique · 26 Feb 2026 · 0 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. The evidence for this is…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #72 · Sourcing › Vendor reports · 20 Feb 2026 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Validating a calculator against hand arithmetic Replied, post #6 · Data & Tools › Calculators · 15 Feb 2026 · 0 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Where a calculator and your own arithmetic disagree, the productive move is to find…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #42 · Data & Tools › Calculators · 8 Feb 2026 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. Mass error checking: enter your observed mass and theoretical mass and check whether the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #39 · Pharmacology › Pharmacokinetics · 16 Dec 2025 · 0 likes Confirming post #38 from a second method, which matters more than confirming it from a second person. Where two sources give different half-lives, check the study…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #69 · Practice › Interactions · 15 Dec 2025 · 27 likes This follows post #66 rather than contradicting it. Offering a way to settle Warfarin and altered intake rather than another opinion about it. Two measurements, taken…
-
Prescription requirements and telehealth models Replied, post #48 · Sourcing › Regulatory · 5 Dec 2025 · 26 likes Prescription requirements and telehealth models would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
When to stop reading forums, including this one Replied, post #51 · Wellbeing › Mental health · 19 Nov 2025 · 8 likes Post #50 is the version of this I will quote in future. One addition. Social and relationship impacts: weight change affects how others perceive and interact with a…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #87 · Sourcing › Vendor reports · 7 Nov 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 19 Oct 2025 · 0 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
What a purity-only report leaves out Replied, post #50 · Sourcing › Independent verification · 17 Oct 2025 · 4 likes The reason purity-only keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Gauge and length selection for subcutaneous injection Replied, post #39 · Devices › Syringes & needles · 13 Oct 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #107 · Evidence › Preprints · 4 Oct 2025 · 14 likes Narrowing post #106, because the general version has more than one answer. If someone has run Citing a preprint properly I would rather read that than my own…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #89 · Practice › Administration · 2 Oct 2025 · 7 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Reading a supplier's product description as a marketing document Replied, post #76 · Compounds › Other compounds · 27 Sep 2025 · 0 likes Confirming post #73 from a second method, which matters more than confirming it from a second person. Thymosin alpha-1 has a regulatory history in several jurisdictions…
-
Are there stupid questions here? A staff answer, at length Replied, post #102 · Start Here › Welcome · 23 Aug 2025 · 4 likes This is the answer, and the reason it is the answer is the more useful part.
-
Guidelines revision: what changed and why — one year on Replied, post #8 · Meta › Announcements · 16 Aug 2025 · 22 likes An honest declaration on Guidelines revision: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #5 · Compounds › Other compounds · 23 Jul 2025 · 0 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Practical note on AOD-9604: write down what you expect before you look. The number…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #34 · Analytics › Home & field testing · 4 Jul 2025 · 0 likes Reading back through the quantitation threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Half-life, steady state, and accumulation worked through Replied, post #54 · Pharmacology › Pharmacokinetics · 2 Jun 2025 · 4 likes Post #52 put the caveat in the right place and I want to underline it. Adding a small correction to the half-life summary above rather than a disagreement with it. The…
-
Pre-registering a personal experiment, seriously Replied, post #76 · Research Methods › N-of-1 designs · 1 Jun 2025 · 16 likes Pre-registering a personal experiment would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #23 · Devices › Syringes & needles · 28 May 2025 · 4 likes Coming back to post #19, because the follow-up matters more than the original answer. Answering the Filter needles question as asked, then the question I think is…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #21 · Practice › Dosing & titration · 12 May 2025 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #111 · Evidence › Journal club · 6 May 2025 · 0 likes Where I part company with post #109, and it is a narrow parting. If you are new and reading this thread for the answer to SURMOUNT-1: the answer is conditional, the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #68 · Evidence › Journal club · 20 Apr 2025 · 3 likes Where I part company with post #67, and it is a narrow parting. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #86 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 0 likes This follows post #84 rather than contradicting it. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #42 · Sourcing › Vendor reports · 31 Mar 2025 · 7 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. I would not lead a decision…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #37 · Practice › Reconstitution · 24 Mar 2025 · 0 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. I would rather say I…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #93 · Analytics › COA interpretation · 17 Mar 2025 · 15 likes The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say. I…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #78 · Analytics › COA interpretation · 13 Mar 2025 · 1 like Counter-ion form has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Deamidation and the close-eluting pair it produces Replied, post #7 · Analytics › Impurities & related substances · 10 Mar 2025 · 0 likes Two things can be true about deamidation at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
What a seizure notice actually says Replied, post #34 · Sourcing › Logistics · 17 Feb 2025 · 2 likes Worth separating two things that post #30 runs together. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on…
-
Canadian access and provincial variation Replied, post #56 · Regional › North America · 5 Feb 2025 · 0 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #34 · Evidence › Journal club · 27 Dec 2024 · 0 likes Post #30 describes the usual case. This is about the unusual one. The baseline characteristics table is the single most useful page for the questions that get asked…
-
Building a sensible monitoring schedule with your prescriber Replied, post #43 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes Where I part company with post #41, and it is a narrow parting. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #82 · Practice › Side effects · 17 Dec 2024 · 5 likes Taking post #79 at face value and following it one step further. The thing about injection-site reactions that took me longest to accept is that a plausible mechanism…
-
Coming back to: When to suspect the method rather than the sample Replied, post #47 · Analytics › Method validation · 9 Dec 2024 · 13 likes That reframing is the whole thing. The facts I already had.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #136 · Clinical › Bloodwork · 23 Oct 2024 · 6 likes Worth separating bring a laboratory as a question about the compound from bring a laboratory as a question about the documentation. They get answered by different…
-
Requesting a page: what makes a good request — what changed since Replied, post #141 · Documentation › Wiki requests · 13 Oct 2024 · 1 like Good question, well framed, and I would like to see it answered properly.
-
Correlation in a self-tracked dataset: what it can support Replied, post #43 · Research Methods › Statistics · 22 Aug 2024 · 7 likes Worth separating two things that post #41 runs together. Survivorship in a self-reporting population biases every aggregate produced from it, and the bias is in the…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #30 · Compounds › Retatrutide · 18 Jul 2024 · 8 likes On dose escalation: the published protocols escalated in defined steps over defined intervals, and those intervals were chosen to manage tolerability. Compressing them…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Started this topic · Compounds › Secretagogues & GH axis · 11 Jul 2024 · 11 likes The question in the title: Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset I will give what I have already checked below so…
-
MHRA statements, read directly — the long version Started this topic · Regional › UK & Ireland · 9 Jul 2024 · 29 likes On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I…